Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 1/2010

01-03-2010 | Review Article

Malignant Appendiceal GIST: Case Report and Review of the Literature

Authors: Ram Elazary, Avraham Schlager, Abed Khalaileh, Liat Appelbaum, Miklosh Bala, Mahmoud Abu-Gazala, Areej Khatib, Tzahi Neuman, Avraham I Rivkind, Gidon Almogy

Published in: Journal of Gastrointestinal Cancer | Issue 1/2010

Login to get access

Abstract

Introduction

Gastro-intestinal stromal tumors (GISTs) of the appendix are a rare entity. To date, only a handful has been described in the literature, all of which have been of the benign type.

Case Report

We present the first reported case of a malignant appendiceal GIST. The tumor was discovered when the patient presented with a peri-appendiceal abscess which appeared suspicious on CT. The abscess was drained and managed medically. The patient responded to antibiotic treatment but subsequent CT and biopsy confirmed the diagnosis of appendiceal GIST, and the patient was started on treatment with imatinab mesylate.

Discussion

One week after initiation of therapy, the patient returned with frank peritonitis necessitating surgery. Abdominal exploration revealed an appendiceal GIST locally invading and perforating adjacent bowel. We describe the complex presentation and course of the case as well as a literature review of the appendiceal GISTs and the current approach to treatment.
Literature
1.
go back to reference Agaimy A, Wusch PH. Gastrointestinal stromal tumours: a regular origin in the muscularis propria, but an extremely diverse gross presentation. Langenbecks Arch Surg. 2006;391:322–9.CrossRefPubMed Agaimy A, Wusch PH. Gastrointestinal stromal tumours: a regular origin in the muscularis propria, but an extremely diverse gross presentation. Langenbecks Arch Surg. 2006;391:322–9.CrossRefPubMed
2.
go back to reference Agaimy A, Pelz AF, Wieacker P, Roessner A, Wunsch PH, Schneider-Stock R. Gastrointestinal stromal tumors of the vermiform appendix: clinicopathologic, immunohistochemical, and molecular study of 2 cases with literature review. Hum Pathol. 2008;39:1252–7.CrossRefPubMed Agaimy A, Pelz AF, Wieacker P, Roessner A, Wunsch PH, Schneider-Stock R. Gastrointestinal stromal tumors of the vermiform appendix: clinicopathologic, immunohistochemical, and molecular study of 2 cases with literature review. Hum Pathol. 2008;39:1252–7.CrossRefPubMed
3.
go back to reference Issakov J, Jiveliouk I, Nachmany I, Klausner J, Merimsky O. A histopathological review of gastrointestinal related mesenchymal tumors: the hidden GIST. Isr Med Assoc J. 2007;9:810–2.PubMed Issakov J, Jiveliouk I, Nachmany I, Klausner J, Merimsky O. A histopathological review of gastrointestinal related mesenchymal tumors: the hidden GIST. Isr Med Assoc J. 2007;9:810–2.PubMed
4.
go back to reference Badalamenti G, Rodolico V, Fulfaro F, et al. Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features. Ann Oncol. 2007;18:136–40.CrossRef Badalamenti G, Rodolico V, Fulfaro F, et al. Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features. Ann Oncol. 2007;18:136–40.CrossRef
5.
6.
go back to reference Emory TS, Sobin LH, Lukes L, et al. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol. 1999;23:82–7.CrossRefPubMed Emory TS, Sobin LH, Lukes L, et al. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol. 1999;23:82–7.CrossRefPubMed
7.
go back to reference Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23:70–83.CrossRefPubMed Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23:70–83.CrossRefPubMed
8.
go back to reference Miettinen M, Sobin LH. Gastrointestinal stromal tumors of the vermiform appendix. Clinicopathologic and immunohistochemical study of four cases. Am J Surg Pathol. 2001;25:1433–7.CrossRefPubMed Miettinen M, Sobin LH. Gastrointestinal stromal tumors of the vermiform appendix. Clinicopathologic and immunohistochemical study of four cases. Am J Surg Pathol. 2001;25:1433–7.CrossRefPubMed
9.
go back to reference Yap WM, Tan HW, Goh SGN, Chuah KL. Appendiceal gastrointestinal stromal tumor. Am J Surg Pathol. 2005;29:1545–7.PubMed Yap WM, Tan HW, Goh SGN, Chuah KL. Appendiceal gastrointestinal stromal tumor. Am J Surg Pathol. 2005;29:1545–7.PubMed
10.
go back to reference Kim KJ, Moon W, Park MI, Park SJ, Lee SH, Chun BK. Gastrointestinal stromal tumor of appendix incidentally diagnosed by appendiceal hemorrhage. World J Gastroenterol. 2007;23:3265–7. Kim KJ, Moon W, Park MI, Park SJ, Lee SH, Chun BK. Gastrointestinal stromal tumor of appendix incidentally diagnosed by appendiceal hemorrhage. World J Gastroenterol. 2007;23:3265–7.
11.
go back to reference Blay JY, Bonvalot S, Casali P, et al. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference on 20–21 March 2004, under the auspices of ESMO. Ann Oncol. 2005;16:566–78.CrossRefPubMed Blay JY, Bonvalot S, Casali P, et al. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference on 20–21 March 2004, under the auspices of ESMO. Ann Oncol. 2005;16:566–78.CrossRefPubMed
12.
go back to reference Joensuu H, Fletcher C, Dimitrijevic S, Silberman S, Roberts P, Demetri G. Management of malignant gastrointestinal stromal tumours. Lancet Oncol. 2002;3:655–64.CrossRefPubMed Joensuu H, Fletcher C, Dimitrijevic S, Silberman S, Roberts P, Demetri G. Management of malignant gastrointestinal stromal tumours. Lancet Oncol. 2002;3:655–64.CrossRefPubMed
13.
14.
go back to reference Rubin and Duensing A. Mechanisms of resistance to small molecule kinase inhibition in the treatment of solid tumors. Lab Invest 2006, 86: 981–6. Rubin and Duensing A. Mechanisms of resistance to small molecule kinase inhibition in the treatment of solid tumors. Lab Invest 2006, 86: 981–6.
15.
go back to reference Verweij J, Casali PG, Zalcberg J, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet. 2004;364:1127–34.CrossRefPubMed Verweij J, Casali PG, Zalcberg J, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet. 2004;364:1127–34.CrossRefPubMed
16.
go back to reference Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol. 2002;33:466–77.CrossRefPubMed Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol. 2002;33:466–77.CrossRefPubMed
17.
go back to reference Fletcher CDM, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459–65.CrossRefPubMed Fletcher CDM, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459–65.CrossRefPubMed
Metadata
Title
Malignant Appendiceal GIST: Case Report and Review of the Literature
Authors
Ram Elazary
Avraham Schlager
Abed Khalaileh
Liat Appelbaum
Miklosh Bala
Mahmoud Abu-Gazala
Areej Khatib
Tzahi Neuman
Avraham I Rivkind
Gidon Almogy
Publication date
01-03-2010
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2010
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-009-9113-8

Other articles of this Issue 1/2010

Journal of Gastrointestinal Cancer 1/2010 Go to the issue

Editorial

Editorial

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.